BioCardia, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
BioCardia, Inc. (BCDA) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-24.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2014-03-24
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2013-09-30 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2012-03-31 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2013 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2011 was $0.04.
- BioCardia, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2010 was -$0.05.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-24 | |||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | ||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-24 | |||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 | $0.00 10-Q · filed 2012-08-10 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | $0.04 10-K · filed 2013-03-22 | |||||
| 2011-09-30 | $0.05 10-Q · filed 2012-11-08 | $0.00 10-Q · filed 2011-11-15 | $0.05 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | $0.05 10-Q · filed 2012-08-10 | $0.05 10-Q · filed 2012-08-10 | ||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | -$0.05 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | -$0.03 10-Q · filed 2011-11-15 | -$0.05 10-Q · filed 2011-11-15 | ||||
| 2010-06-30 | -$0.01 10-Q/A · filed 2011-11-17 | -$0.01 10-Q/A · filed 2011-11-17 | $0.01 10-Q · filed 2011-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |